Cargando…
Choosing the right model for STEMI care in India – Focus should remain on providing timely fibrinolytic therapy, for now
Autores principales: | Karthikeyan, Ganesan, Mantoo, Mohsin Raj, Bhargava, Balram |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9903390/ https://www.ncbi.nlm.nih.gov/pubmed/36510894 http://dx.doi.org/10.4103/ijmr.ijmr_600_22 |
Ejemplares similares
-
How to Choose the Right Mate
por: Arcangioli, Benoit
Publicado: (2013) -
MR-Guided Focused Ultrasound for Refractory Epilepsy: Where Are We Now?
por: Labate, Angelo, et al.
Publicado: (2023) -
Trends and Outcomes of Fibrinolytic Therapy for STEMI: Insights and Reflections in the COVID-19 Era
por: Elbadawi, Ayman, et al.
Publicado: (2020) -
Ethical Implications of Donor Type for Uterus Transplantation: Why
We Should Remain Wary of Using Living Donors
por: Bruno, Bethany, et al.
Publicado: (2020) -
The effects of fibrinolytic before referring STEMI patients: A systematic review and meta-analysis
por: Mongkhon, Pajaree, et al.
Publicado: (2017)